Skip to content

Insider · CIK 0001792987

Robert L Ferrara

director

Files at PHIO (Phio Pharmaceuticals Corp.). First filing May 21, 2025, latest Jun 11, 2025.

Robert L Ferrara files SEC Form 4 as director at PHIO (Phio Pharmaceuticals Corp.). Since May 21, 2025, Robert L Ferrara has reported 2 open-market buys worth $11k and 0 open-market sells worth $0, the latest filed on Jun 11, 2025.

A track record needs three past buys with six months of prices behind them; Robert L Ferrara has 0, so none is measured yet.

The newest scored trade: bought $6,050 of PHIO on Jun 10, 2025, filed Jun 11, 2025, scored 39 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$11k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PHIO: Phio Pharmaceuticals Corp.

PHIOOct 9, 2026 · close 0.98

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
39Weak
PHIObuy 2
Phio Pharmaceuticals Corp.
$6,050
2,500 shares
+19%+145% from low-63% from high
37Weak
PHIObuy 2
Phio Pharmaceuticals Corp.
$4,550
2,500 shares
+23%+81% from low-72% from high

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2025PHIO
Phio Pharmaceuticals Corp.
AGrant or award
Common Stock, $.0001 par value
+23,000$0.00$038,666Sep 15, 2025
Sep 11, 2025PHIO
Phio Pharmaceuticals Corp.
AGrant or award
Common Stock, $.0001 par value
+23,100$0.00$038,766Sep 15, 2025
Jun 10, 2025PHIO
Phio Pharmaceuticals Corp.
POpen-market purchase
Common stock, $0.0001 par value
+2,500$2.42$6,05015,666Jun 11, 2025
May 20, 2025PHIO
Phio Pharmaceuticals Corp.
POpen-market purchase
Common stock, $0.0001 par value
+2,500$1.82$4,55013,166May 21, 2025

Questions about Robert L Ferrara

Answered from the filings on this page, as of the latest one.

Is Robert L Ferrara buying or selling?

Not in the last 12 months. Robert L Ferrara's latest open-market trade on SEC Form 4 was bought $6,050 of PHIO on Jun 10, 2025.

How did Robert L Ferrara's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert L Ferrara has 0.

Where does Robert L Ferrara file Form 4?

Robert L Ferrara has filed Form 4 at PHIO (Phio Pharmaceuticals Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Robert L Ferrara: insider trades and track record | InsiderTell